Arcutis Biotherapeutics, Inc. - Common stock (ARQT)
17.01
+0.24 (1.43%)
Arcutis Biotherapeutics Inc is a biopharmaceutical company focused on developing innovative treatments for dermatological conditions
The company is dedicated to addressing unmet medical needs by leveraging its expertise in immunology and dermatology to create topical therapies that enhance the quality of life for patients suffering from skin disorders. Through its research and development efforts, Arcutis aims to deliver effective and safe solutions for common conditions such as psoriasis, eczema, and other inflammatory skin diseases, emphasizing patient-centric approach and scientific rigor in its product development pipeline.
Frequently Asked Questions
Is Arcutis Biotherapeutics, Inc. - Common stock publicly traded?
Yes, Arcutis Biotherapeutics, Inc. - Common stock is publicly traded.
What exchange does Arcutis Biotherapeutics, Inc. - Common stock trade on?
Arcutis Biotherapeutics, Inc. - Common stock trades on the Nasdaq Stock Market
What is the ticker symbol for Arcutis Biotherapeutics, Inc. - Common stock?
The ticker symbol for Arcutis Biotherapeutics, Inc. - Common stock is ARQT on the Nasdaq Stock Market
What is the current price of Arcutis Biotherapeutics, Inc. - Common stock?
The current price of Arcutis Biotherapeutics, Inc. - Common stock is 17.01
When was Arcutis Biotherapeutics, Inc. - Common stock last traded?
The last trade of Arcutis Biotherapeutics, Inc. - Common stock was at 4:00 pm EDT on March 21st, 2025
What is the market capitalization of Arcutis Biotherapeutics, Inc. - Common stock?
The market capitalization of Arcutis Biotherapeutics, Inc. - Common stock is 854.61M
How many shares of Arcutis Biotherapeutics, Inc. - Common stock are outstanding?
Arcutis Biotherapeutics, Inc. - Common stock has 50.24M shares outstanding.